Related Experiment Video

Updated: Jul 2, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Preventing Cancer by Inhibiting Ornithine Decarboxylase: A Comparative Perspective on Synthetic vs. Natural Drugs

Preeti Nanda Sahu1, Anik Sen1

  • 1Department of Chemistry, (CMDD Lab) GITAM (Deemed to be), University, Rushikonda, Visakhapatnam, 530045, India.

Chemistry & Biodiversity
|February 26, 2024
PubMed

Insights

Researchers explored synthetic and natural compounds as inhibitors for Ornithine decarboxylase (ODC), an enzyme linked to cancer development. Targeting ODC offers a promising strategy for cancer prevention and treatment by modulating polyamine metabolism.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Ornithine decarboxylase (ODC) is a key enzyme in polyamine metabolism.
  • ODC activation and elevated polyamine levels are implicated in the development of numerous cancers.
  • ODC protein levels significantly influence cellular activity, impacting tumor suppression.

Purpose of the Study:

  • To investigate synthetic and natural inhibitors of Ornithine decarboxylase (ODC).
  • To explore the connection between polyamine metabolism, ODC, and oncogenesis.
  • To identify novel therapeutic strategies for cancer prevention and treatment.

Main Methods:

  • Review of synthetic and naturally occurring ODC inhibitors.
  • Evaluation of the inhibitory patterns and effectiveness of various compounds.
  • Assessment of newly utilized natural compounds, including flavonoids.

Main Results:

  • ODC targeting is a viable strategy for cancer intervention.
  • Synthetic moieties and natural flavonoids show potential as ODC inhibitors.
  • Natural compounds demonstrate promise for enhanced inhibition of ODC.

Conclusions:

  • Modulating polyamine metabolism via ODC inhibition is crucial for cancer control.
  • Development of novel ODC inhibitors, both synthetic and natural, is a promising avenue for cancer prevention.
  • Further research into natural compounds could yield effective anti-cancer agents.
Keywords:
ODC enzymecomparisonmolecular dockingnatural inhibitorssynthetic inhibitors

More Related Videos

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles

Published on: March 18, 2015

11.6K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.5K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K